RapidAI recently closed a $75 million Series C funding round led by Vista Credit Partners. The company offers an AI platform that helps hospital care teams triage and treat stroke patients more quickly.
The company's AI-enabled imaging software identifies a suspected pulmonary embolism and delivers real-time notifications to physicians so the patient can be treated quickly.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.